Knowledge HQ

Speed up your immune cell therapy manufacturing with Ready-to-Use GMP Cytokines. Now available in three convenient formats—ProPak closed system bags, process-sized vials, and liquid formulations—these high-quality cytokines eliminate unnecessary steps, reduce handling errors, and ensure consistency in your workflow. Whether you're optimizing T cell expansion or streamlining cytokine delivery, our animal-free GMP and RUO proteins are designed for efficiency and reliability. Download this flyer to see how you can enhance your process and accelerate your path to the clinic with ease.

Unlock the full potential of NK cell therapies with ExCellerate™ NK Cell Expansion Media—a cutting-edge, animal-free solution designed to streamline your research and clinical applications. Whether you're working with iPSC-derived NK cells, PBMCs, or purified NK cells, this innovative media ensures robust expansion, sustained viability, and optimized cytotoxic function without the complexities of traditional serum-based systems. Ready to accelerate your NK cell research with a simplified, high-performance solution? Download the flyer now to see how ExCellerate™ can enhance your workflow and drive better results.

Ignacio Nunez discusses the importance of collaboration and partnerships, such as that between ScaleReady and Cellular Origins, and the impact of these on drug development and patient accessibility.

The best technology is often the simplest. Quiet, elegant, brilliant. A revolution in T-Cell culture technology. The G-Rex Bioreactor.

Discover a game-changing approach to T cell expansion. This application note showcases how the G-Rex bioreactor and Bio-Techne reagents deliver hands-free, zero-touchpoint cell growth. Learn how to streamline your manufacturing, boost efficiency, and maintain cell health—all with a simple fill-and-forget workflow.

Ignacio Nunez, COO of CellReady, discusses the importance of sustainability in cell and gene therapy manufacturing at ISCT 2024.

Ignacio Nunez, COO of CellReady, discusses current projects and what the future holds during ASGCT 2024.

Leading industry experts discuss critical strategies to make life-changing treatments more accessible and affordable for patients during ISCT 2024. Hear from top executives at Germfree, Cellular Origins, and CellReady as they discuss innovative solutions to overcome industry challenges. Moderated by ScaleReady.

For Cell and Gene Modified Cell Therapy (CGT) manufacturing, a robust contamination control strategy (CCS) is necessary to ensure compliance with current Good Manufacturing Practices (cGMP). A successful CCS helps ensure safety, purity, efficacy, and quality of a CGT product. CGT manufacturers should implement Closed Systems wherever possible and employ equipment that maintains a stable, clean environment with advanced monitoring. We show that Closed System G-Rex® bioreactors combined with Thermo ScientificTM HeracellTM ViosTM CR carbon dioxide (CO2) incubators enable simplified parallel processing capabilities and significantly reduced contamination risks in a highly efficient production.

Rizwan Chaudrey spoke with Ignacio Núñez, COO, CellReady, at ISCT 2024  about the company, its relationship with ScaleReady, what they are showcasing tat ISCT and what makes them unique.

ExCellerate T Cell Media supports robust ex vivo CD3+ T cells, while maintaining high viability. This media is optimized to be used with Bio-Techne R&D SystemsTM cytokines and is compatible Excellerate media is compatible with closed system G-Rex bioreactors.